Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. Board of Directors

Board of Directors

Geoffrey M. Glass
Chairman of the Board

Geoffrey M. Glass has been a member of the Board of Directors since July 2018 and became Chairman of the Board in December 2018. Since May 2015, Mr. Glass has served as President of Clear Sciences,

View Bio »
Gregory J. Divis
CEO

Gregory J. Divis was named Chief Executive Ocer in June of 2019, after having served as Chief Operating Ocer (named in March 2018) and Executive Vice President and Chief Commercial Ocer (named in

View Bio »
Eric Ende M.D.
Director

Dr. Eric J. Ende has been a member of the Board of Directors since December 2018. Dr. Ende is the President of Ende BioMedical Consulting Group, a privately-held consulting company focused on the

View Bio »
Mark McCamish M.D., Ph.D.
Director

Dr. Mark A. McCamish has been a member of the Board of Directors since December 2019. Since May 2017, Dr. McCamish has served as President, Chief Executive Officer and member of the board of

View Bio »
Linda S. Palczuk
Director

Linda S. Palczuk, has been a member of the Board of Directors since July 2018. Since September 2019, Ms. Palczuk has been the Chief Operating Officer and a director of Envara Health, Inc., a medical

View Bio »
Peter Thornton
Director

Peter Thornton has been a member of the Board of Directors since June 2017. He is the Chief Financial Officer of Technopath Clinical Diagnostics, an Irish company that provides quality control

View Bio »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2